Mather Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $832K | Sell |
7,747
-370
| -5% | -$39.7K | 0.01% | 296 |
|
|
2025
Q1 | $819K | Sell |
8,117
-924
| -10% | -$93.2K | 0.01% | 279 |
|
|
2024
Q4 | $807K | Buy |
9,041
+2,420
| +37% | +$216K | 0.01% | 266 |
|
|
2024
Q3 | $555K | Sell |
6,621
-1,033
| -13% | -$86.6K | 0.01% | 347 |
|
|
2024
Q2 | $524K | Buy |
7,654
+1,283
| +20% | +$87.9K | 0.01% | 405 |
|
|
2024
Q1 | $368K | Sell |
6,371
-722
| -10% | -$41.7K | 0.01% | 393 |
|
|
2023
Q4 | $410K | Buy |
7,093
+72
| +1% | +$4.16K | 0.01% | 389 |
|
|
2023
Q3 | $371K | Buy |
7,021
+386
| +6% | +$20.4K | 0.01% | 390 |
|
|
2023
Q2 | $359K | Buy |
+6,635
| New | +$359K | 0.01% | 419 |
|